Bluejay Diagnostics (BJDX) Current Assets (2021 - 2023)
Bluejay Diagnostics' Current Assets history spans 3 years, with the latest figure at $3.2 million for Q4 2023.
- On a quarterly basis, Current Assets fell 72.68% to $3.2 million in Q4 2023 year-over-year; TTM through Dec 2023 was $3.2 million, a 72.68% decrease, with the full-year FY2023 number at $3.2 million, down 72.68% from a year prior.
- Current Assets hit $3.2 million in Q4 2023 for Bluejay Diagnostics, down from $6.5 million in the prior quarter.
- Over the last five years, Current Assets for BJDX hit a ceiling of $20.7 million in Q4 2021 and a floor of $3.2 million in Q4 2023.
- Historically, Current Assets has averaged $12.0 million across 3 years, with a median of $11.8 million in 2022.
- Biggest five-year swings in Current Assets: crashed 42.94% in 2022 and later crashed 72.68% in 2023.
- Tracing BJDX's Current Assets over 3 years: stood at $20.7 million in 2021, then plummeted by 42.94% to $11.8 million in 2022, then crashed by 72.68% to $3.2 million in 2023.
- Business Quant data shows Current Assets for BJDX at $3.2 million in Q4 2023, $6.5 million in Q3 2023, and $6.6 million in Q2 2023.